GleamWall
中文EN

CWLXF C21 Investments Inc. Annual reports only

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 831609 · Fiscal year ends 03/31

Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY8.3%
TTM net income YoY18.3%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin41.7%
Operating margin7.0%
Net margin-9.9%
FCF margin3.4%
EBITDA margin12.4%

Returns

ROE-12.0%
ROA-5.8%
ROIC (approx.)4.6%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets53.3%
Debt / equity0.00x
Current ratio1.30x
Interest coverage12.17x

Cash quality & payout

Operating cash flow / net income-0.42x
Accruals ratio-8.3%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue$32.61M$30.12M
Cost of revenue$19.01M$17.56M
Gross profit$13.61M$12.56M
SG&A expense$11.33M$11.28M
Operating income$2.28M$1.28M
Interest expense$187,241$293,675
Pretax income$1.38M$394,921
Income tax$4.61M$4.15M
Net income-$3.24M-$3.97M
EBITDA$4.06M$2.99M
EPS (basic)-0.03-0.03
EPS (diluted)-0.03-0.03
Weighted avg. shares (diluted)118.47M120.59M
Balance sheet
Cash & equivalents$2.23M$2.63M
Receivables$57,084$124,827
Inventory$4.59M$4.05M
Current assets$8.31M$7.50M
PP&E, net$2.30M$2.67M
Goodwill$28.54M$28.54M
Intangibles$6.41M$8.09M
Total assets$54.42M$57.00M
Current liabilities$6.39M$7.96M
Total liabilities$28.99M$28.32M
Shareholders' equity$25.43M$28.68M
Shares outstanding117.84M118.00M
Cash flow statement
Operating cash flow$1.36M$1.37M
Capital expenditure$244,838$406,733
Free cash flow$1.12M$958,920
Investing cash flow-$219,838-$3.45M
Financing cash flow-$1.54M$1.67M
Depreciation & amortization$1.78M$1.71M
Stock-based compensation$236,779$849,559
Share buybacks$103,034$276,730

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.